Background-Ventricular tachycardia (VT) is an important cause of late morbidity and mortality in repaired congenital heart disease. The substrate often includes anatomic isthmuses that can be transected by radiofrequency catheter ablation similar to isthmus block for atrial flutter. This study evaluates the long-term efficacy of isthmus block for treatment of re-entry VT in adults with repaired congenital heart disease. Methods and Results-Thirty-four patients (49±13 years; 74% male) with repaired congenital heart disease who underwent radiofrequency catheter ablation of VT in 2 centers were included. Twenty-two (65%) had a preserved left and right ventricular function. Patients were inducible for 1 (interquartile range, 1-2) VT, median cycle length: 295 ms (interquartile range, 242-346). Ablation aimed to transect anatomic isthmuses containing VT re-entry circuit isthmuses. Procedural success was defined as noninducibility of any VT and transection of the anatomic isthmus and was achieved in 25 (74%) patients. During long-term follow-up (46±29 months), all patients with procedural success (18/25 with internal cardiac defibrillators) were free of VT recurrence but 7 of 18 experienced internal cardiac defibrillator-related complications. One patient with procedural success and depressed cardiac function received an internal cardiac defibrillator shock for ventricular fibrillation. None of the 18 patients (12/18 with internal cardiac defibrillators) with complete success and preserved cardiac function experienced any ventricular arrhythmia. In contrast, VT recurred in 4 of 9 patients without procedural success. Four patients died from nonarrhythmic causes. Conclusions-In patients with repaired congenital heart disease with preserved ventricular function and isthmus-dependent re-entry, VT isthmus ablation can be curative. (Circ Arrhythm Electrophysiol. 2015;8:102-109.
T he population of adults with repaired congenital heart disease (rCHD) is growing as improved surgical techniques are extending survival. 1 However, rCHD is still associated with late morbidity and mortality because of ventricular arrhythmias (VA). 2, 3 VA encompass polymorphic ventricular tachycardia, ventricular fibrillation, and monomorphic ventricular tachycardia (MVT) with potentially different underlying substrates requiring different treatment strategies. Patients who experience any VA are considered candidates for internal cardiac defibrillator (ICD) implantation for prevention of sudden cardiac death. 4 ICDs, however, do not prevent VA and are frequently associated with devicerelated complications and inappropriate therapy in rCHD. [5] [6] [7] An important option to prevent MVT is radiofrequency catheter ablation (RFCA), 8, 9 which may be considered as alternative to ICDs in patients with an otherwise low risk for sudden cardiac death. 10 In scar-related VTs, noninducibility has often been used as procedure end point, and has not been a reliable predictor of freedom from ventricular tachycardia (VT) during follow-up. 11 MVT in adults with rCHD often depends on well-defined anatomic isthmuses. 8, 9 These isthmuses can be transected by RFCA and demonstration of conduction block provides a defined procedural end point similar to that for achieving block in the common right atrial flutter isthmus. We hypothesized that this isthmus ablation approach may be sufficiently reliable for ablation to be considered as sole therapy for selected patients with VT because of rCHD. 9 The aims of this study were (1) to evaluate the acute and long-term efficacy of isthmus ablation for treatment of VT in a large population of adults with rCHD and (2) to identify patients in whom RFCA may be an alternative to ICD therapy.
Methods

Patient Population
The series consisted of consecutive patients with rCHD, who underwent RFCA of VT aiming to target anatomic isthmuses in 2 centers (Brigham and Women's Hospital and Leiden University Medical Center) between 2001 and 2012. The medical records of all patients were reviewed for type of malformation, surgical history, device implantation, presenting symptoms, documented arrhythmias, and medication at referral. Nonpaced 12-lead ECGs recorded at admission were analyzed for QRS duration. The occurrence of nonsustained VT (≥3 consecutive beats, rate >120 beats per minute, lasting <30 s) was captured from Holter recordings. The review of medical records was approved by the hospital human subject protection committee. Nine patients were included in our initial report 7 years ago. 
Hemodynamic Evaluation Before Ablation
Echocardiographic and cardiac MRI (CMR) studies performed before ablation were collected. The echocardiographic studies were reviewed by an independent imaging cardiologist (E.R.H.) experienced in CHD and blinded to outcome. Right ventricular (RV) systolic function was semiquantitatively assessed and classified as poor, moderately reduced, mildly reduced, or good. 12, 13 Tricuspid annular plane systolic excursion was measured but not used in case of tricuspid valve annuloplasty. Mildly reduced or good RV function with a tricuspid annular plane systolic excursion ≥14 mm was considered as preserved. The left ventricular ejection fraction was assessed by Simpson method and classified as poor (<30%), moderately reduced (30% to 39%), mildly reduced (40% to 54%), or good (≥55%). Left ventricular ejection fraction ≥40% was considered preserved left ventricular (LV) function. If available, cardiac volumes and volume-derived parameters were evaluated by CMR. In case of discrepancy, CMR results determined the definitive classification. Designation of preserved cardiac function required both preserved RV and LV function.
Electrophysiology Study, Electroanatomical Mapping, and Ablation
Programmed electric stimulation was performed from the RV apex and right ventricular outflow tract with 3 extra stimuli at 3 basic cycle lengths, including administration of isoproterenol. The method to obtain a three-dimensional reconstruction of all specific anatomic isthmuses and targeting the VT-related isthmus by ablation has been previously described in detail. 9 Briefly, three-dimensional RV and/or LV electroanatomical bipolar voltage mapping during sinus rhythm or RV pacing was performed using a venous or retrograde access. In transposition of the great arteries, the morphological RV was approached via the aorta in the case of an atrial switch and via venous access in the case of an arterial switch operation. To identify prosthetic material adjacent to normal myocardium and surgical scars, high-output pacing was performed at all low-voltage sites (<1.5 mV). Sites with a pacing threshold >10 mA were tagged as electrically unexcitable scar. 14 Tricuspid and mitral annuli were identified by atrial and ventricular electrograms of approximately equal amplitudes. Areas of electrically unexcitable scar (eg, incisions and patch material) and valve annuli were considered to be boundaries of anatomic isthmuses. The critical re-entry circuit isthmus of each induced VT was determined by diastolic activity and slowing or termination during RF delivery or entrainment during VT or by pace-mapping (pace-match, ≥10/12 leads). 9, 14 If the critical isthmus site was located within an anatomically defined isthmus the anatomic isthmus was considered critical and the adjoining anatomic boundaries were connected by a linear RF lesion. RF ablation was performed with an open saline-irrigated catheter (power limit, 50 W) in 32 patients (Thermocool) or an 8-mm tip catheter (power limit, 70 W) in 2 patients. In all studies, high-output pacing (10 mA, 2 ms) along the line was performed and no capture was considered as a transected anatomic isthmus. Block was further supported by the presence of double potentials or a change in activation sequence during sinus rhythm or RV pacing after ablation ( Figure 1 ). More recently, differential pacing was performed to confirm bidirectional conduction block. After transection of the anatomic isthmus programmed stimulation was repeated.
Complete procedural success was defined as noninducibility of any VT and transection of the critical anatomic isthmuses; partial success, if only nonclinical VTs could be induced or transection of the corresponding anatomic isthmus of the nonclinical VT could not be performed or no potential re-entry circuit site for a nonclinical VT could be identified; failure, if the clinical or presumed clinical VT remained inducible or transection of the corresponding anatomic isthmus could not
WHAT IS KNOWN
• Ventricular arrhythmias are an important cause of late morbidity and mortality in the growing population of adults with repaired congenital heart disease.
• The majority of these ventricular arrhythmias are fast, monomorphic and thereby life-threatening ventricular tachycardia (VT).
• Small studies have demonstrated that the VT substrate in repaired congenital heart disease often includes anatomic isthmuses that can be transected by radiofrequency catheter ablation with favorable outcome.
WHAT THE STUDY ADDS
• In a large group of repaired congenital heart disease patients, transection of VT-associated anatomic isthmuses by radiofrequency catheter ablation is feasible in 74% of the patients and is highly effective to prevent VT recurrence during long-term follow-up.
• In selected patients with repaired congenital heart disease, with preserved left and right ventricular function, and anatomic isthmus dependent re-entry VT in whom other ventricular arrhythmias mechanisms are unlikely isthmus ablation may be reasonable as sole therapy for the arrhythmia.
be performed or no potential re-entry circuit site for a clinical VT could be identified. The procedural outcome was considered undetermined if the induction protocol was not repeated after ablation.
Follow-Up
In patients without an ICD before ablation, an ICD was recommended if indicated according to current guidelines. 4 Antiarrhythmic drugs (AAD) were discontinued at the discretion of the electrophysiologist. Patients were followed according to the institutional protocol. All episodes of spontaneous sustained VA and appropriate and inappropriate ICD therapy were recorded. VT was considered sustained when ≥30 s or terminated by the ICD. Recurrence was defined as documented sustained VT or symptoms highly suspicious for sustained VA. Device-related complications were registered. Mortality was assessed from hospital records. For patients that were not followed at the 2 institutes' outside records of the clinical and device follow-ups were obtained.
Statistical Analysis
Continuous variables are reported as mean±SD or median with the interquartile range, according to variable distribution and categorical variables as percentages and frequencies. Patients with and without complete procedural success were compared using Student t test, Mann-Whitney U test, χ 2 test, and Log-rank test where appropriate. Odds and hazard ratios of sex, age (at repair), pulmonary valve replacement, LV function, RV function, cardiac function, number and average VT cycle length of induced VTs were calculated for acute procedural outcome, sustained MVT and VA occurrence during follow-up using univariate logistic regression and hazard Cox proportional hazard regression analysis where appropriate. The Kaplan-Meier method was used to plot freedom of sustained MVT in patients with and without complete procedural success and freedom of appropriate ICD therapy and inappropriate shocks in patients with complete procedural success and preserved cardiac function. P value of 0.05 was considered significant. SPSS software (20.0 Windows; SPSS Inc, Chicago, IL) was used.
Results
Patient Characteristics
The population consisted of 34 adults (25 male, 48.6±13.2 years) with rCHD who had undergone total repair at a median age of 10.0 (interquartile range, 4.5-18.5) years. Twenty-eight had undergone repair of tetralogy of Fallot (TOF), 2 of transposition of the great arteries (Mustard baffle in 1 and arterial switch operation in 1), 2 of ventricular septal defect (VSD) with bicuspid aortic valve or congenital pulmonary stenosis, 1 of atrioventricular septal defect, and 1 of congenital pulmonary stenosis. In 10 prior palliative, shunting had been performed and in 13 patients initial repair was followed by reoperation, which was pulmonary valve replacement in 9 at a mean age of 36±12 years. At referral, 14 patients (41%) had an ICD. Twenty-seven patients presented with spontaneous sustained monomorphic VTs (SMVT) documented on ECGs (18) or ICDs (14) . In the remaining 7 patients, SMVT was suspected and could be induced during programmed electric stimulation. Mean QRS duration (nonpaced; n=29) was 161±29 ms; in 21% QRS duration exceeded 180 ms.
Hemodynamic Characteristics
Echocardiography was performed in 32 patients and 11 had undergone CMR. In 32 patients, imaging was performed during admission for RFCA or within the preceding 6 months. In 2 patients, imaging studies that were acquired >6 months before RFCA and after RFCA showed similar results suggesting stable cardiac function. In only 1 patient, imaging results were discrepant (RV function moderately reduced on echocardiography, but preserved [right ventricular ejection fraction, 41%] on CMR). RV function was preserved in 71% and LV function in 82% of the patients. Both the RV and LV functions were preserved in 22 (65%) patients (Table 1) .
Mapping and Ablation Outcome
Thirty-four patients had 61 different VTs (median of 1 [1] [2] VT/pt) inducible with a median VT cycle length of 295 ms (interquartile range, 242-346). In all patients with VT documentation the (presumed) clinical VT could be induced. In all 7 patients without previous VT documentation, only 1 VT could be reproducibly induced and was considered the clinical VT. Mapping revealed 6 different anatomic isthmuses (Figure 2) . In all patients, ≥1 isthmus could be identified (median of 2 [2] [3] isthmus/patient). Isthmus 1 was bordered by the tricuspid annulus and a previous RV-incision/right ventricular outflow tract-patch and was present in 30 patients; isthmus 2 by a previous RV-incision and the pulmonary valve and present in 7 patients. Isthmus 3 was bordered by the pulmonary valve and VSD-patch, present in 30 patients and isthmus 4 was bordered by the VSD-patch and the tricuspid annulus and present in 7 patients. 9 Isthmus 5 was bordered by the aortic root and a basal septal scar in 1 patient 15 and isthmus 6 was bordered by the mitral annulus and a basal-posterolateral LV scar in 1 patient. In all 34 patients, the anatomic isthmus related to the (presumed) clinical VT could be identified. In 10 patients, ≥2 VTs shared the same anatomic isthmus. Furthermore, 9 patients had 2 anatomic isthmus related to different VTs (additional mapping data are provided in Table I in the Data Supplement).
Complete procedural success was achieved in 25 patients (21 TOF, 2 D-TGA, 1 VSD, and 1 atrioventricular septal defect), partial success in 3 (2 TOF and 1 VSD) and the procedure failed in 4 (TOF) patients. Ablation failure or partial success was probably because of the hypertrophy of the targeted anatomic isthmus in 3 TOF patients and an interposed pulmonary homograft in 2 TOF patients. In 1 patient (VSD), RFCA was withheld because of the proximity of the His bundle and in 1 TOF patient, no critical re-entry circuit site for 2 VTs could be identified. In 2 patients with impaired cardiac function, no reinduction was performed (length of the procedure, induced VT that degenerated to ventricular fibrillation requiring defibrillation). There was no difference in procedural success between rCHD patients with and without rTOF (P=0.675). Cardiac function was preserved in 18 of 25 patients with complete success, in 4 of 7 patients with partial success or procedural failure and in none of the 2 patients with undetermined procedural outcome. On univariable analysis, LV function (P=0.01) and the number of induced VTs (P=0.02) were related to an unsuccessful procedure ( Table 2) .
The average procedure, fluoroscopy and RF time were respectively 221±73, 46±21, and 22±16 minutes. There was no difference in procedure, fluoroscopy, and RF time between patients with and without complete procedural success. Two patients had procedural complications. One patient with poor cardiac function required intensive care unit admission after February 2015 cardioversion of a hypotensive VT followed by low cardiac output. He fully recovered the following day. One patient had femoral access site bleeding requiring transfusion. There was no procedural-related mortality.
Follow-Up
Twenty-seven (79%) patients were discharged with an ICD, Table 3 . Five of the 25 patients with complete success were discharged with AAD (amiodarone 1 and sotalol 4) because of supraventricular arrhythmias (n=4) and/or presentation with an electrical storm (n=2). Fifteen of the 18 patients with complete procedural success and preserved cardiac function were discharged without any AAD. Four of the 9 patients without complete procedural success received AAD (amiodarone 2 and sotalol 2). During long-term follow-up of 46±28 months, all patients with complete procedural success remained free of SMVT recurrence (Figure 3) . None of the 18 patients with complete success and preserved cardiac function experienced any sustained VA. One patient with complete procedural success but poor cardiac function received an ICD shock for ventricular fibrillation. Spontaneous SMVT recurred in 4 of 9 patients without complete procedural success and were terminated by the ICD. In all 4 patients, the difference between targeted and spontaneous VT cycle length was <30 ms, suggesting recurrence of the same VT. Four patients died during follow-up, 2 of heart failure (no complete success), 1 of gastrointestinal carcinoma, and 1 of leukemia.
No complete procedural success and decreased LV function (P=0.01) were predictors for SMVT occurrence during follow-up (Table 4 ). No complete procedural success (P=0.02), impaired LV function (P=0.01), and impaired cardiac function (P=0.05) were predictors for any VA occurrence (Table 4) .
ICD-Related Complications
Ten of the 27 ICD recipients experienced ≥1 ICD-related complications during follow-up: lead fracture (n=1), ICD extraction because of infection (n=4) and ≥1 inappropriate shocks (n=6) in response to supraventricular tachycardia (n=5) or RV lead over sensing (n=1). Twelve of the 18 patients with complete procedural success and preserved cardiac function were discharged with an ICD and 5 (42%) of them experienced ICD-related complications.
Discussion
To the best of our knowledge, this is the largest series of VT ablation in patients with rCHD (all available data provided in Table II in the Data Supplement). Furthermore, ablation was performed with the same systematic approach irrespective of the type of malformation and type of repair, targeting anatomic isthmuses. We found that transection of VT-associated anatomic isthmuses by RFCA is feasible in 74% of patients and is highly effective to prevent VT recurrence during longterm follow-up. Of importance, in patients with complete procedural success and preserved cardiac function, our findings suggest that this substrate-based approach may be considered curative. None of these patients experienced arrhythmias during follow-up ranging from 3 to 128 months, but 42% experienced ICD-associated complications. Only 3 were on AAD mainly because of supraventricular arrhythmias.
The Substrate for Fast VT and Sudden Cardiac Death
VA are an important cause of morbidity and mortality in CHD. In rTOF, monomorphic VT is the most frequently documented VA accounting for >80% of all VA episodes. 6 The cumulative incidence of sustained VT and SD has been estimated to be 11.9% and 8.3%, respectively at 35 years after repair of TOF and it has been suggested that SD is often because of sustained VT. 16 Of interest, mapping studies performed for both tolerated and hemodynamically untolerated VTs demonstrated that the majority of monomorphic VTs are because of macro re-entry with critical isthmuses located within anatomic isthmuses. 8, 9 When rapid, these VTs may be fatal even in the presence of a preserved cardiac function. The median VT rate in the current series was 203 beats per minute and for rTOF patients 211 beats per minute, which is similar to the VT rate reported in a recent series of TOF patients receiving ICDs. 6 Moderate-to-severe systemic and subpulmonary dysfunction defined as EF<40% has been associated with sudden arrhythmic death in patients with CHD. 17 However, two thirds of patients with CHD who died suddenly had preserved systemic and subpulmonary function, which is comparable to our population. 17, 18 These findings support the concern that untreated, fast monomorphic VTs is an important cause of sudden cardiac death when it occurs in CHD with preserved ventricular function.
Outcome of Ablation
In our series, the substrate of all clinical or presumed clinical VTs was located within an anatomic isthmus and we failed to identify an anatomic isthmus for only 2 of 61 induced VTs. Repaired TOF constitute the largest subgroup in whom VT ablation is reported and comprised 82% of patients in the current series. However, SMVT related to anatomic isthmuses also occurs in other malformations repaired with surgical scars and patch material, and these can be effectively treated by the same systematic approach. All VT-related anatomic isthmuses could be successfully transected in 25 patients resulting in noninducibility of any VT. None of these 25 patients experienced any monomorphic VT during a mean follow-up of 46 months. This absence of VT is remarkable compared with the 9.8% annual rate of appropriate ICD shocks in TOF patients who receive an ICD after experiencing VA. 6 This finding supports the hypothesis that the substrate for the fast and monomorphic VTs is indeed confined to the anatomic isthmuses and can be successfully abolished by blocking these isthmuses. The suggested ablation approach may be comparable to isthmus ablation for cavotricuspid isthmus-dependent flutter, which also has high acute and longterm success rates. Our findings suggest that isthmus ablation with complete procedural success may be considered curative in patients in whom other ventricular arrhythmia mechanisms are unlikely, and who have preserved cardiac function. These patients had no arrhythmia recurrences and low all-cause and cardiac mortality.
Procedural Failure
Procedure failure seemed to have an anatomic basis in 6 of 9 patients. In 3 patients, the anatomic isthmus (isthmus 1 in 1 and isthmus 3 in 2 patients) could not be transected, most likely because of hypertrophied myocardium, despite the use of steerable sheaths and irrigated catheters. In 2 patients, an implanted pulmonary homograft, covering parts of the infundibular septum prevented transection of anatomic isthmus 3. In 1 patient, RFCA was withheld to avoid heart block (isthmus 4). The cumulative incidence of VT recurrence after procedure failure was 100%. Therefore, surgical transection of anatomic isthmuses seems a reasonable consideration in those patients who undergo reoperation for pulmonary valve regurgitation and in whom intraoperative ablation can be performed safely. After a failed endocardial approach of a hypertrophied free wall isthmus an epicardial approach may be considered for refractory VTs. However, epicardial access is likely to be hampered by adhesions after previous surgery and should, therefore, be performed in co-operation with a surgeon.
ICD Therapy
The favorable long-term results in patients with procedural success and preserved cardiac function suggest that selected patients may perhaps not benefit from ICD therapy. ICD-related complications occurred in 42%, which is in line with previous reports. 6, 7 However, larger studies with longer follow-up are required to exclude that other VA mechanisms may be operative in patients with successful ablation of anatomic isthmus-related VT and preserved cardiac function. In patients with impaired LV function ICD implantation is important, as these patients have a significant risk of arrhythmia recurrences. 6 As in other cardiomyopathies with depressed cardiac function, heart failure-related VA mechanisms may be operative. In our series, 1 patient with procedural success for SMVT and depressed cardiac function received an ICD shock for ventricular fibrillation. Our results support the current guidelines stating that ICD implantation is not recommended in patients with CHD and spontaneous VT, when the VT can be successfully treated with surgery or RFCA, provided, however, that cardiac function is preserved. 10 Patients discharged without ICD should undergo regular assessment of cardiac function according to the guidelines. 
Limitations
This study is limited by design and number of patients. Therefore, it is not possible to adjust for confounding in the prediction of acute and long-term outcome. In addition, the results of a case series from 2 high volume centers may not be translated to other less experienced groups. Testing for bidirectional block of the anatomic isthmus has evolved over time and only in the latter patients pacing manoeuvres were performed. However, no capture along the line and change of activation sequence as procedural outcome were associated with no VT recurrence and may already be, therefore, a sufficient end point for a linear lesion.
Conclusions
In patients with rCHD with preserved left and right ventricular function and anatomic isthmus-dependent re-entry, VT isthmus ablation can be curative.
